Drug-induced purposeless chewing: animal model of dyskinesia or nausea?
- PMID: 1979178
- DOI: 10.1007/BF02244098
Drug-induced purposeless chewing: animal model of dyskinesia or nausea?
Abstract
Drug-induced purposeless chewing movements in rodents are often considered to represent movement disorders or dyskinesias. We have compared the ability of drugs to induce chewing and retching or emesis in squirrel monkeys; such studies are not possible in rodents, which do not vomit. Acute administration of oxotremorine (3.3-33 micrograms/kg IM), SKF38393 (1-30 mg/kg SC) or ipecacuanha (0.5-0.75 mg/kg PO) caused dose-related increases in purposeless chewing which was frequently associated with retching and emesis. Treatment with haloperidol (0.015-0.06 mg/kg IM) did not induce chewing. Rather, haloperidol decreased spontaneous chewing at doses of 0.03 and 0.06 mg/kg. Our findings indicate that at least some drug-induced oral behaviours in rodents may reflect nausea rather than dyskinesia.
Similar articles
-
Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation.Psychopharmacology (Berl). 1991;103(4):503-12. doi: 10.1007/BF02244250. Psychopharmacology (Berl). 1991. PMID: 1676528
-
Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.Psychopharmacology (Berl). 1993;113(2):157-66. doi: 10.1007/BF02245692. Psychopharmacology (Berl). 1993. PMID: 7855176
-
Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat.Psychopharmacology (Berl). 1993;112(4):428-36. doi: 10.1007/BF02244890. Psychopharmacology (Berl). 1993. PMID: 7871053
-
SCH 23390 dissociated from conventional neuroleptics in apomorphine climbing and primate acute dyskinesia models.Life Sci. 1985 Dec 23;37(25):2355-63. doi: 10.1016/0024-3205(85)90102-x. Life Sci. 1985. PMID: 3908866
-
Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats.Psychopharmacology (Berl). 1985;85(1):71-9. doi: 10.1007/BF00427326. Psychopharmacology (Berl). 1985. PMID: 2858901
Cited by
-
Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.Psychopharmacology (Berl). 1995 Feb;117(4):403-12. doi: 10.1007/BF02246211. Psychopharmacology (Berl). 1995. PMID: 7604140
-
Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosets.Psychopharmacology (Berl). 1991;105(3):303-9. doi: 10.1007/BF02244422. Psychopharmacology (Berl). 1991. PMID: 1686813
-
Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset.Psychopharmacology (Berl). 1995 Feb;117(3):275-86. doi: 10.1007/BF02246102. Psychopharmacology (Berl). 1995. PMID: 7770603
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical